Chrysin inhibits hypertrophic scar formation through TGF-β/Smad signaling pathways

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Molecular Histology

• Publication date

  2025-09-06

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s10735-025-10576-3PMID 40913688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Positional Information in Determining Dermal Fibroblast Diversity.

  2024cited by this paper
• Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver fibrosis.

  2024cited by this paper
• CLC-3 regulates TGF-β/smad signaling pathway to inhibit the process of fibrosis in hypertrophic scar

  2024cited by this paper
• ALA-PDT promotes the death and contractile capacity of hypertrophic scar fibroblasts through inhibiting the TGF-β1/Smad2/3/4 signaling pathway.

  2023cited by this paper
• Ursolic acid inhibits human dermal fibroblasts hyperproliferation, migration, and collagen deposition induced by TGF-β via regulating the Smad2/3 pathway.

  2023cited by this paper
• Chrysin ameliorates synovitis and fibrosis of osteoarthritic fibroblast-like synoviocytes in rats through PERK/TXNIP/NLRP3 signaling

  2023cited by this paper
• Gallic Acid Treats Hypertrophic Scar in Rabbit Ears via the TGF-β/Smad and TRPC3 Signaling Pathways

  2023cited by this paper
• Traditional Chinese medicine for hypertrophic scars—A review of the therapeutic methods and potential effects

  2022cited by this paper
• Prevention and management of hypertrophic scars after laparoscopic surgery using silicone gel sheets: a pilot study

  2022cited by this paper
• Mechanomodulatory Biomaterials Prospects in Scar Prevention and Treatment.

  2022cited by this paper
• Highly water-soluble diacetyl chrysin ameliorates diabetes-associated renal fibrosis and retinal microvascular abnormality in db/db mice

  2022cited by this paper
• TSG‐6 inhibits hypertrophic scar fibroblast proliferation by regulating IRE1α/TRAF2/NF‐κB signalling

  2022cited by this paper
• Ivermectin inhibits cell proliferation and the expression levels of type I collagen, α‑SMA and CCN2 in hypertrophic scar fibroblasts.

  2021cited by this paper
• Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.

  2021cited by this paper
• Dermal Fibroblast Heterogeneity and Its Contribution to the Skin Repair and Regeneration

  2021cited by this paper
• 5‑Aminosalicylic acid attenuates paraquat‑induced lung fibroblast activation and pulmonary fibrosis of rats.

  2021cited by this paper
• Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders

  2021cited by this paper
• Chrysin Ameliorates Cyclosporine-A-Induced Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial–Mesenchymal Transition

  2021cited by this paper
• Bioflavonoid Galangin Suppresses Hypertrophic Scar Formation by the TGF-β/Smad Signaling Pathway

  2021cited by this paper
• Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides

  2020cited by this paper
• The Latest Strategy for Keloid and Hypertrophic Scar Prevention and Treatment: The Nippon Medical School (NMS) Protocol.

  2020cited by this paper
• The myofibroblast at a glance

  2020cited by this paper
• Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.

  2020cited by this paper
• Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.

  2020cited by this paper
• A novel chrysin derivative produced by gamma irradiation attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in Balb/c mice.

  2019cited by this paper
• Chrysin: Pharmacological and therapeutic properties.

  2019cited by this paper
• Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action.

  2018cited by this paper
• Extracorporeal shock wave therapy with low-energy flux density inhibits hypertrophic scar formation in an animal model

  2018cited by this paper
• Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids

  2018cited by this paper
• TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders

  2018cited by this paper
• LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblasts

  2018cited by this paper
• Usnic acid inhibits hypertrophic scarring in a rabbit ear model by suppressing scar tissue angiogenesis.

  2018cited by this paper
• Chinese expert consensus on clinical prevention and treatment of scar+

  2018cited by this paper
• Hypertrophic scarring: the greatest unmet challenge after burn injury.

  2016cited by this paper
• Anti-photoageing and anti-melanogenesis activities of chrysin

  2016cited by this paper
• The Many Roles of PCNA in Eukaryotic DNA Replication.

  2016cited by this paper
• Growth factor pathways in hypertrophic scars: Molecular pathogenesis and therapeutic implications.

  2016cited by this paper
• High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars

  2015cited by this paper
• Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.

  2015cited by this paper
• Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts

  2015cited by this paper
• Fibroblasts and myofibroblasts in wound healing

  2014cited by this paper
• Fibroblasts in fibrosis: novel roles and mediators

  2014cited by this paper
• Promoted activation of matrix metalloproteinase (MMP)‐2 in keloid fibroblasts and increased expression of MMP‐2 in collagen bundle regions: implications for mechanisms of keloid progression

  2009cited by this paper
• Deep dermal fibroblasts contribute to hypertrophic scarring

  2008cited by this paper
• Cutaneous Wound Healing

  2007cited by this paper
• Fibroblast mechanics in 3D collagen matrices.

  2007cited by this paper
• Hypertrophic Scar Fibroblasts Have Increased Connective Tissue Growth Factor Expression after Transforming Growth Factor- Stimulation

  2005cited by this paper
• Hypertrophic Scar Fibroblasts Have Increased Connective Tissue Growth Factor Expression after Transforming Growth Factor-β Stimulation

  2005cited by this paper
• Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

  2003cited by this paper
• Hypertrophic scar tissues and fibroblasts produce more transforming growth factor‐β1 mRNA and protein than normal skin and cells

  2000cited by this paper
• Fibroblasts, myofibroblasts, and wound contraction

  1994cited by this paper

• Chrysin promotes the survival of flaps through the TLR4/NF-κB/NLRP3 signaling pathway.

  2025cites this paper